Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance.

Authors: Grossmann, V  Kohlmann, A  Eder, C  Haferlach, C  Kern, W  Cross, NC  Haferlach, T  Schnittger, S 
Citation: Grossmann V, etal., Leukemia. 2011 May;25(5):877-9. doi: 10.1038/leu.2011.10. Epub 2011 Feb 22.
Pubmed: (View Article at PubMed) PMID:21339759
DOI: Full-text: DOI:10.1038/leu.2011.10



Disease Annotations
Objects Annotated

Additional Information

CRRD Object Information
CRRD ID: 10450882
Created: 2016-01-22
Species: All species
Last Modified: 2016-01-22
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.